Chile’s health regulatory agency approved on Wednesday the emergency use of the COVID-19 Pfizer vaccine, which could be applied to people over 16 years old. Chile is the first country in South America to allow the use of the immunizer, reported DW. In Latin America, Costa Rica and Mexico already approved Pfizer’s COVID-19 vaccine.
Pfizer also filed with Brazil’s health regulator, Anvisa, the results of phase 3 of trials for its immunizer, a pace for the emergency use release, reported UOL. Brazil’s government wants to buy 70 million doses of this vaccine, according to the media outlet.
Also on Wednesday, Brazil’s government officially launched the national immunization plan against COVID-19. The document brings the promise to buy Coronavac, produced by the Sao Paulo’s Butantan Institute in partnership with the Chinese pharmaceutical company Sinovac. The text also includes new priority groups in the immunization queue as public transport workers, homeless people and population deprived of liberty, reported G1.
While Sao Paulo’s government said it will start vaccinating on January 25, Brazil’s health minister Eduardo Pazuello spoke of the beginning of national immunization in February.